Oncology
November 4, 2018
Revlimid(Lenalidomide) in Dano Health view Lenalidomide with the trade name Revlimid is imitative of thalidomide which was introduced in 2004 and developed by modification of the structural backbone of thalidomide. It […]
October 28, 2018
Avastin (Bevacizumab) in Dano Health Bevacizumab with the trade name Avastin was the first available angiogenesis inhibitor in the United States. It is a “monoclonal antibody” and “anti-angiogenesis” drug […]
October 2, 2018
Opdivo (Nivolumab) in Dano Health view Opdivo under the generic name Nivolumab was discovered at Medarex and developed by Medarex and Ono Pharmaceutical medicine supplier. Bristol-Myers Squibb, the […]